Closed-loop Functional Spinal Cord Stimulation in Patients With Spinal Cord Injury

NCT ID: NCT04969042

Last Updated: 2021-07-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE1

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-01

Study Completion Date

2027-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this experiment is to evaluate the efficacy of Closed-loop Functional Spinal Cord Stimulation on Walking Rehabilitation in Patients after Spinal Cord Injury

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The whole course will last around 12 months, during which there will be: Pre-implant evaluations and standard rehabilitation (6-10 weeks), Stimulator implantation and stimulation optimization (4-8 weeks), Rehabilitation training with stimulation (6 months). At the end of the protocol, the study aims to make the patients walk better and faster.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Cord Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stimulation

Participants will receive pre-implantation rehabilitation, implantation of the closed-loop spinal cord stimulator, and stimulation (according to the functional mapping) assisted rehabilitation post-implantation during the trial.

Group Type EXPERIMENTAL

Pins Medical G122 RS

Intervention Type DEVICE

G122RS model implanted spinal cord stimulation device, which could give closed-loop functional stimulation in the epidural space

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pins Medical G122 RS

G122RS model implanted spinal cord stimulation device, which could give closed-loop functional stimulation in the epidural space

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18\~70
* Spinal cord injury staging(AIS) A,B,C or D
* Level of lesion is T10 and above
* Distance between lesion and conus \>60mm
* Injured Time \> 3 months
* Capable of participating rehabilitation program
* Agree to comply with all conditions of the study and to attend all required study training and visits

Exclusion Criteria

* With Obvious psychiatric disorder that cannot complete relevant questionaires
* Cognitive impairment
* Severe autonomic reflex disorder
* Severe muscle atrophy and joint contracture
* Cannot participate in spinal cord stimulation surgery or follow-up visits
* Life expectancy less than 12 months
* Abnormal blood or other physiological examinations that cannot conduct surgery, such as blood coagulation disorder or kidney/liver abnormalities
* Uncontrollable hypertension, heart diseases, respiratory diseases or took related medicine in last 3 months
* Unsuitable candidates in PI's perspective
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing Tsinghua Changgeng Hospital

OTHER

Sponsor Role collaborator

Luming Li

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Luming Li

Director of National Engineering Laboratory for Neuromodulation

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Luming Li, PhD

Role: PRINCIPAL_INVESTIGATOR

National Engineering Laboratory for Neuromodulation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Engineering Laboratory for Neuromodulation

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yang Lu, MD

Role: CONTACT

+8656119530

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yang Lu, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202000325

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.